Back to Search
Start Over
493 Safety Profile and Signal of Efficacy of a Non-Fcr-Binding, Fully Human Anti-Cd3 Monoclonal Antibody in Patients with Moderate to Severe Crohn's Disease- Results of a Phase I/Iia, Double Blind, Placebo-Controlled, Randomized, Dose Escalation Study
- Source :
- Gastroenterology. 134:A-67
- Publication Year :
- 2008
- Publisher :
- Elsevier BV, 2008.
Details
- ISSN :
- 00165085
- Volume :
- 134
- Database :
- OpenAIRE
- Journal :
- Gastroenterology
- Accession number :
- edsair.doi...........0752b09855b7abf4797ab627f80a708e
- Full Text :
- https://doi.org/10.1016/s0016-5085(08)60317-0